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DOI: 10.1039/c004521gThis paper describes a SlipChip to perform digital PCR in a very simple and inexpensive format. The
fluidic path for introducing the sample combined with the PCR mixture was formed using elongated
wells in the two plates of the SlipChip designed to overlap during sample loading. This fluidic path was
broken up by simple slipping of the two plates that removed the overlap among wells and brought each
well in contact with a reservoir preloaded with oil to generate 1280 reaction compartments (2.6 nL each)
simultaneously. After thermal cycling, end-point fluorescence intensity was used to detect the presence
of nucleic acid. Digital PCR on the SlipChip was tested quantitatively by using Staphylococcus aureus
genomic DNA. As the concentration of the template DNA in the reaction mixture was diluted, the
fraction of positive wells decreased as expected from the statistical analysis. No cross-contamination
was observed during the experiments. At the extremes of the dynamic range of digital PCR the standard
confidence interval determined using a normal approximation of the binomial distribution is not
satisfactory. Therefore, statistical analysis based on the score method was used to establish these
confidence intervals. The SlipChip provides a simple strategy to count nucleic acids by using PCR. It
may find applications in research applications such as single cell analysis, prenatal diagnostics, and
point-of-care diagnostics. SlipChip would become valuable for diagnostics, including applications in
resource-limited areas after integration with isothermal nucleic acid amplification technologies and
visual readout.Introduction
This paper describes a simple SlipChip-based method for
counting nucleic acid molecules via digital PCR. Digital PCR1–9
is a powerful method to detect rare cells and count cells, DNA,
and RNA, and relies on the single-molecule sensitivity of PCR.
At the single molecule level, confining the molecule in a small
volume increases the relative concentration, thus increasing
the sensitivity.10 In digital PCR, after a statistical analysis, the
number of ‘‘positive’’ wells approximately corresponds to the
number of target molecules in the sample.
Digital PCR has been previously demonstrated on a multiwell
plate,1,5 and in a number of microfluidic formats.2,6,11–13 Valve-
controlled microfluidic chips have adapted digital PCR for
various applications, such as cell analysis2,4 and prenatal diag-
nosis;6,14 however, this method still requires a complex fabrication
process and a pneumatic system to control the opening and
closing of the valves. Another system for digital PCR uses picolitre
droplets in a microfluidic device for single-copy PCR and RT-
PCR.11,12 Droplet-based approaches are attractive for a wide
range of applications,15,16 but they require pumping equipment
and equipment for rapid readout. A spinning disk platform was
also recently developed for digital PCR,13 but it still requires
centrifugation for fluid control. Emulsion PCR,17 microdroplet,18
and engineered nanolitre droplets19 can be also potentially applied
for digital PCR, but these systems require either mechanical
agitation or pumps to generate the small volume droplets.Department of Chemistry and Institute for Biophysical Dynamics, The
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quantitative PCR20 can also be adapted for digital PCR, but it still
requires mechanical loading and manual sealing operations.
A simple, inexpensive platform is still an unmet need to make
digital PCR a routine procedure in laboratories or resource-
limited settings. In this paper, we describe such a system based on
the SlipChip platform.21–26 The SlipChip relies on movement, or
‘‘slipping’’, of two plates imprinted with wells and ducts to
convert continuous fluidic paths used for filling a device into
discreet volumes suitable for compartmentalization of nucleic
molecules required for digital PCR. Therefore, it can achieve
compartmentalization without requiring a complex fabrication
process or a complex manipulation system. As the plates are
slipped past one another, the wells and ducts are brought in and
out of contact to combine reagents and perform reactions. The
SlipChip platform has been shown to handle multistep processes
on many small volumes in the context of protein crystallization21–23
and immunoassays.25 In parallel studies, multiplexed PCR was
successfully demonstrated in the SlipChip:26 no cross-
contamination was seen when different preloaded primers
were used to screen a sample to identify the presence of
pathogens, and the design of the SlipChip was modified to
allow room for thermal expansion of the aqueous PCR
solution during thermal cycling. Here, we test and quantify
the performance of SlipChip using single-molecule amplifica-
tion in digital PCR.
Experimental section
Chemicals and materials
All solvents and salts purchased from commercial sources were
used as received unless otherwise stated. SsoFast EvaGreenThis journal is ª The Royal Society of Chemistry 2010
Supermix (2X) was purchased from Bio-Rad Laboratories
(Hercules, CA). Bovine serum albumin (BSA) was purchased
from Roche Diagnostics (Indianapolis, IN). All primers were
ordered from Integrated DNA Technologies (Coralville, IA).
Mineral oil (DNase, RNase, and Protease free) and DEPC-
treated nuclease-free water were purchased from Fisher Scientific
(Hanover Park, IL). Dichlorodimethylsilane was purchased from
Sigma-Aldrich (St Louis, MO). Staphylococcus aureus genomic
DNA (ATCC number 6538D-5) was purchased from American
Type Culture Collection (Manassas, VA). PCR tubes and barrier
pipette tips were purchased from Molecular BioProducts (San
Diego, CA). Mastercycler and in situ adapter were purchased
from Eppendorf (Hamburg, Germany). Spectrum food colors
(red food dye) were purchased from August Thomsen Corp
(Glen Cove, NY). Soda-lime glass plates coated with chromium
and photoresist were purchased from Telic Company (Valencia,
CA). Photomasks were obtained from CAD/Art Services, Inc.
(Bandon, OR). Amorphous diamond coated drill bits
were obtained from Harvey Tool (0.030 inch cutter diameter,
Rowley, MA).Fabrication of SlipChip for digital PCR
The procedure for fabricating the SlipChip was based on the
procedure described in previous work.21 The soda-lime glass
plate coated with chromium and photoresist was aligned with
a photomask containing the design for the wells (both circular
and elongated) of the SlipChip, and AZ 1500 positive photoresist
was exposed using standard exposure protocols. Immediately
after exposure, the glass plate was immersed in 0.1 mol L1
NaOH to remove the areas of the photoresist exposed to UV
light. The exposed underlying chromium layer was removed
using a chromium etchant (a solution of 0.6 : 0.365 mol L1
HClO4/(NH4)2Ce(NO3)6). The glass plate was then rinsed with
Millipore water and dried with nitrogen gas. The back of the
glass plate was taped with PVC sealing tape to protect the glass,
and the taped glass plate was then immersed in a glass etching
solution (1 : 0.5 : 0.75 mol L1 HF/NH4F/HNO3) to etch the
glass surface where chromium coating was removed in
the previous step. Etching speed was controlled by controlling
the temperature, and 35 min etching time at 40 C produced wells
that were 50 mm deep.
The glass plate with an etched pattern of wells was thoroughly
cleaned with reverse-osmosis purified (Millipore) water and
ethanol and dried with nitrogen gas. The glass plate was oxidized
in a plasma cleaner for 100 seconds and immediately placed in
a desiccator with 50 mL of dichlorodimethylsilane. A vacuum was
then applied for one hour for gas-phase silanization. The silanized
glass plate was rinsed with chloroform, acetone, and ethanol, and
then dried with nitrogen gas. In order to be reused, the glass plate
could be cleaned with piranha acid (3 : 1 sulfuric acid : hydrogen
peroxide) and silanized again as described above.Assembling and loading the SlipChip
The mineral oil was filtered and degassed before using. The
SlipChip was assembled under mineral oil. The bottom plate was
first immersed into the oil in a Petri dish, with the patterned side
facing up. The top plate was then laid on top of the bottom plateThis journal is ª The Royal Society of Chemistry 2010with the patterned side facing down. The two plates were
assembled as shown in Fig. 1d–f under the stereomicroscope for
precise alignment, and then the aligned SlipChip was fixed using
binder clips.
Aqueous solution was loaded into the SlipChip by pipetting
into the inlet. A dead-end filling method27 was applied to fill all
the wells evenly, so that there was no outlet for aqueous solution.
As the aqueous solution flowed in, the mineral oil present in the
wells was expelled through the gap between the glass plates. To
avoid accidental injection of air bubbles into the chip, 6 mL of
aqueous solution were used for injection until the entire fluidic
path was filled with aqueous solution.
PCR amplification
Primer sequences for the nuc gene found in S. aureus were
selected from a previous publication:28 50-GCGATT-
GATGGTGATACGGTT-30 (primer 1) and 50-AGC-
CAAGCCTTGACGAACTAAAGC-30 (primer 2). The reaction
master mixture consisted of 10 mL of 2X SsoFast EvaGreen
Supermix, 0.5 mL of primer 1 (10 mmol L1), 0.5 mL of primer 2
(10 mmol L1), 2 mL of 10 mg mL1 BSA solution, 5 mL of
nuclease-free water and 2 mL of S. aureus genomic DNA
(gDNA) solution. The S. aureus gDNA solution was serially
diluted using 1 BSA solution (0.01 mg mL1), and the range of
final template concentrations in the PCR mixture was: 1 ng
mL1, 100 pg mL1, 10 pg mL1, 1 pg mL1, 100 fg mL1, 10 fg
mL1, and 1 fg mL1. The concentration of DNA stock solution
was measured spectrophotometrically by NanoDrop (Thermo
scientific). The amplification was performed using a PCR ther-
mocycling machine (Eppendorf). To amplify the DNA, an
initialization step of 2 min at 94 C was used to activate the
enzyme. Next, a total 35 cycles of amplification were performed
as follows: a DNA denaturation step of 1 min at 94 C, a primer
annealing step of 30 s at 55 C, and a DNA extension step of
30 s at 72 C. After the final cycle, a final elongation step was
performed for 5 min at 72 C. Then the PCR products were
stored in the cycler at 4 C before imaging.
DNA copy number calculation
We estimated 1 ng of S. aureus gDNA contains approximately
3  105 copies. The volume of reaction solution in each
compartment was 2.6 nL, and at the gDNA concentration of
1 ng mL1, the copy number of gDNA per well was expected to be
approximately 8  102 copies per well.
Image acquisition and analysis
Bright field images were acquired with a Leica stereomicroscope.
All fluorescence images were acquired by using a digital camera
(C4742, Hamamatsu Photonics, Japan) mounted to a Leica DMI
6000 B epi-fluorescence microscope with a 5/0.15 NA objective
and L5 filter at room temperature. All fluorescence images were
corrected by a background image obtained with a standard
fluorescent slide and then stitched together using MetaMorph
software (Molecular Devices, Sunnyvale, CA). Each image in
Fig. 3 was automatically stitched together by using forty fluo-
rescence images. The intensity levels were adjusted to the same
values for all images.Lab Chip, 2010, 10, 2666–2672 | 2667
Fig. 1 Schematic drawing and bright field images show the design and mechanism of the SlipChip for digital PCR. The top plate is outlined with a black
solid line, the bottom plate is outlined with a blue dotted line, and red represents the sample. (a) Schematic drawing shows the design of the entire
assembled SlipChip for digital PCR after slipping. (b) Schematic drawing of part of the top plate. (c) Schematic drawing of part of the bottom plate. (d–f)
The SlipChip was assembled such that the elongated wells in the top and bottom plates overlapped to form a continuous fluidic path. (g–i) The aqueous
reagent (red) was injected into SlipChip and filled the chip through the connected elongated wells. (j–l) The bottom plate was slipped relative to the top
plate such that the fluidic path was broken up and the circular wells were overlaid with the elongated wells, and aqueous droplets were formed in each
compartment. (d, g and j) Schematic of the SlipChip; (e, h and k) zoomed in microphotograph of the SlipChip; (f, i and l) microphotograph of the entire
SlipChip.Measuring size variation of droplets formed in the SlipChip
The PCR mastermix was injected into the assembled SlipChip as
described above. Two-dimensional fluorescent images were
taken, and all the images were corrected by using a background
image and thresholded to the same value. The number of pixels
comprising each droplet, along with the mean and standard
deviation for all 1280 droplets, was determined using Meta-
Morph software. The variation of the two-dimensional cross-
section of the droplets formed in the SlipChip was calculated to
be approximately 5% across all 1280 wells. This variation could
be further decreased by optimizing the geometry of the wells on
both the top and bottom plates.
Results and discussion
The design of the device was symmetric to increase the density of
wells (Fig. 1a). Arrays of circular wells filled with oil were2668 | Lab Chip, 2010, 10, 2666–2672designed in both the top and bottom plates, and overlapping
elongated wells in both top and bottom plates (Fig. 1b–c), were
used to introduce the sample (Fig. 1d–i). Upon slipping, isolated
compartments were created (Fig. 1j–l), and an aqueous droplet of
uniform size was generated in each individual compartment. This
SlipChip contained no ducts to load the sample; instead, each
plate was patterned with alternating rows of the elongated wells
and circular wells for a total 1280 reaction compartments. The
elongated wells were 400 mm long, 200 mm wide, and 50 mm deep,
and the circular wells were 200 mm in diameter and 50 mm in
depth (Fig. 1). In the initial configuration, the elongated wells in
the top and bottom plates overlapped to form a continuous
fluidic path (Fig. 1d–f). Using overlapping elongated wells
instead of wells connected by ducts provided two advantages: (i)
no sample was wasted in the ducts and (ii) the pressure drop in
the device was reduced, allowing 1280 wells to be filled easily by
a single pipetting step (Fig. 1g–i). By slipping the top plateThis journal is ª The Royal Society of Chemistry 2010
relative to the bottom plate, the elongated wells were separated
and each was centered on top of a circular well containing the
lubricating fluid (mineral oil) (Fig. 1j–l). For digital PCR, the
primer was added to the PCR mixture instead of being preloaded
into the circular wells as previously described.26 The elongated
wells were designed so that the width of the elongated wells was
the same as the diameter of the circular wells. This design had
three advantages: (1) it enabled the resulting aqueous droplets to
be centered in the wells, allowing for better imaging. (2) It also
produced droplets of consistent volume (2.6 nL). (3) It created
an aqueous droplet surrounded by oil within the well, as in the
multiplexed PCR SlipChip,26 eliminating potential problems
associated with thermal expansion during thermal cycling.
During thermal cycling, the lubricating fluid and the aqueous
PCR mixture expand more than the glass material of the Slip-
Chip due to the different thermal expansion coefficients of theFig. 2 Amplification of single copy of gDNA by using digital PCR on
the SlipChip. (a) Fluorescence microphotograph shows part of the Slip-
Chip before thermal cycling, and the linescan presents the fluorescence
intensity along the yellow dashed line. The white dashed line outlines the
edge of droplets formed in the wells. (b) Fluorescence microphotograph
acquired at the same position after thermal cycling: only the center well
shows a significant increase in fluorescence from background. The line-
scan presents the fluorescence intensity along the yellow dashed line.
Fig. 3 Digital PCR on the SlipChip with different concentrations of S. aureu
DNA template ranging from 100 pg mL1 to 1 fg mL1. Concentrations of gDN
Control, no wells showed positive signal when no target DNA template was
This journal is ª The Royal Society of Chemistry 2010three materials, potentially leading to cross-contamination due
to leakage of the aqueous solution into the gap between the two
plates. In the multiplexed PCR SlipChip, we solved this problem
by overlapping a square well containing an aqueous PCR
mixture with a circular well containing oil, producing a droplet
suspended in oil and centered in the square well.26 For digital
PCR, we achieved the same result by using elongated wells
containing the aqueous PCR mixture centered over circular wells
filled with the lubricating fluid.
We first tested digital PCR on the SlipChip with 10 fg mL1 of
S. aureus gDNA. At this concentration, there was less than 1
copy of gDNA per 100 wells on average, and PCR amplification
of single copy of gDNA was achieved. A linescan of the digital
PCR SlipChip before and after thermal cycling (Fig. 2) shows
that the fluorescence intensity for wells containing a single DNA
template increased significantly while the fluorescence intensity
for wells without DNA template did not increase. This linescan
also verified that there was no cross-contamination in the Slip-
Chip, as the fluorescence intensity for negative wells adjacent to
a well containing DNA template did not change.
We quantified the performance of this device using five
concentrations of genomic DNA from S. aureus (Fig. 3). The
digital PCR SlipChip was able to detect template DNA at
concentrations as low as 1 fg mL1. The expected concentration of
the DNA template was presented as number of copies per well
(cpw), and the concentration of the original DNA stock solution
was measured spectrophotometrically. The detailed method for
calculating the cpw is presented in the Experimental section. As the
DNA template in the PCR master mixture was diluted, the fraction
of positive wells decreased proportionally (Fig. 3a–e and 4). We
saw no evidence of contamination, as a control sample containing
no template DNA did not give any positive results (Fig. 3f).
We repeated the experiments for each concentration (n $ 3),
and generated a curve relating the fraction of positive wells to the
dilution factor (Fig. 4a). The dilution factor was calculated from
the initial concentration of 1 ng mL1. A regression fit of eqn (1)
(linearized form of the Poisson equation) was used to charac-
terize the performance of the device. In eqn (1), f is the number of
positive wells, c is the initial concentration of the sample prior tos gDNA. (a–e) Digital PCR on the Slipchip with a serial dilution of target
A and expected copies per well (cpw) are indicated above each figure. (f)
loaded.
Lab Chip, 2010, 10, 2666–2672 | 2669
Fig. 4 Quantified results of digital PCR experiments. (a) Experimental
average fraction of positive wells as a function of dilution factor from an
initial concentration of 1 ng of S. aureus gDNA per mL. Error bars
represent standard deviation of the experiment (n $ 3 for the experi-
mental measurement of fraction of positive wells). (b) Regression fit of
results from the four most diluted samples (lowest dilution factors).dilution (in genome copies per well), x is the fractional dilution
factor of the original concentration (in units of concentration1,
where 10 fold dilution corresponds to x ¼ 0.1), and n is the total
number of wells. n  f ¼ s, where s is the number of negative
wells. (See ESI† for derivation.)
ln(n  f) ¼ c  x + ln n (1)
Constraining the intercept to equal ln 1280 when plotting x vs.
ln(n  f) will give a slope equal to the negative of the original
concentration (Fig. 4b). Fitting the equation without constrain-
ing the intercept gives a comparable result, supporting the
appropriate use of the fit as a method of estimation. The excellent
fit obtained (Fig. 4b) indicates that the device produces self-
consistent results that follow Poisson statistics.
We note that the method of eqn (1), while suitable for testing
the performance of the device, is not always correct for extracting
the starting concentration of the undiluted sample. Under non-
ideal conditions, where different dilutions may give inconsistent
results, this method does not weigh all observed results equally.
Most probable number (MPN) theory, which maximizes the
probability of the combined binomials for the different dilu-
tions,29 is more appropriate for analysis of dilution series that
lead to non-ideal results. Results obtained in this paper were
sufficiently self-consistent that both methods produced equiva-
lent results. Using data for the four most diluted samples, eqn (1)
gives original concentration c of 616 genome copies per well and
MPN theory gives 625 genome copies per well. Using data for the
five most diluted samples, eqn (1) gives original concentration c
of 505 genome copies per well and MPN theory gives 597 genome
copies per well. MPN calculations are more laborious; therefore,
when the results at multiple dilutions are self-consistent, eqn (1)
provides a good approximation.
The estimated original concentration from the fit (Fig. 4b,
slope of regression line), 6.2  102 genome copies per well,
was within a factor of 1.3 of the concentration determined by
spectrophotometry (8  102 genome copies per well, see
Experimental section, ‘‘DNA copy number calculation’’). We
consider this level of agreement satisfactory because there is
some uncertainty associated with the concentration determined
by spectrophotometry. Because the exact length of the genome
for this strain is unknown and there is uncertainty in the
absorption coefficient used, the measured 8  102 genome
copies per well is an approximation. In addition, potential
pipetting error during dilution and potential losses of DNA2670 | Lab Chip, 2010, 10, 2666–2672during sample preparation could increase the deviation between
the two estimates.
Next, we performed a more detailed analysis to establish the
confidence intervals to interpret each digital measurement. We
had two goals: first, we wished to check that there were no
significant spatial biases in the performance of the device. For
example, losses of DNA on the surface of the device during
filling could lower the actual concentration of DNA towards the
‘‘outlet’’ side of the device, leading to lower frequency of posi-
tive wells on that side of the device. Second, we wished to
establish the reliability of the measurements at the extremes of
the dynamic range of this chip, both at low concentrations
resulting in only a few positive wells or at high concentration
resulting in only a few negative wells. Confidence intervals (CIs)
using a normal approximation of the distribution, which is
binomial with the probability derived from the Poisson equa-
tion, are given by eqn (2),30–34 sometimes referred to as the Wald
method, where p is the probability that a well is negative, n is
the total number of wells, and a is the coefficient that sets the
confidence interval.
CI ¼ p a
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð pð1  pÞÞ=n
p
(2)
For the 95% CI, a is 1.96. If the starting concentration is
known, p can be calculated using the Poisson equation, which
simplifies to p ¼ el to determine the probability that a well is
negative, where l is the average concentration per well. The
probability that a well contains at least one particle and so gives
a positive result is then 1  p. Alternatively, if the concentration
is unknown, the number of negative wells can be used to estimate
the probability using p ¼ s/n. This simple approach for calcu-
lating CIs is applicable when many compartments (>50 is
a common cutoff) are available and when concentrations can be
controlled to avoid extreme results (very low or very high frac-
tion of positive wells).
It is well known30,33 but not always appreciated that eqn (2)
cannot be used to evaluate confidence intervals ifn is not sufficiently
large or if p is close to 0 or 1, as the normal approximation is not
acceptable under these conditions. For example, blind use of the
Wald method to interpret results with up to 3 negative wells out of
1280 gives a lower limit on p that is negative. Additionally, in the
range where the criteria for suitability are not met, the Wald
method gives intervals that are too small, so the nominal 95% CI
has an actual coverage of less than 95%. The range of p where this
approach is acceptable is dependent on n, so a definitive cutoff for
either variable is not possible, and there is a variety of criteria
available to determine when using the Wald method is valid.33 To
calculate CIs, numerous more universally applicable methods
exist.30,34–39 Here, we chose to use the ‘‘score’’ or ‘‘Wilson’’
method30,33,35,37,39 given in eqn (3), which derived in a similar fashion
















The score method never gives nonsensical ranges, its average
coverage is 95%, and it closely fluctuates around the value overThis journal is ª The Royal Society of Chemistry 2010
a much greater portion of the range than the Wald method. It is
more appealing than ‘‘exact’’ methods35–38,40 that must be solved
iteratively, because the equation can still be rapidly used.
We applied the score method to analyze spatial uniformity of
the signal from the devices. We separated each device into four
quadrants, and determined whether or not the value of the
quadrant fell within the 95% CI of the average value. For the four
lowest concentrations presented in Fig. 4b, 50 out of 52 quad-
rants (96%) fell within the 95% CI, supporting the observation
that no positional biases were occurring due to filling effects
(Table S1, ESI†).
We also applied the score method to calculate the original
concentration, including confidence intervals from the raw data
(Fig. 5). Our calculations show that, over the majority of the
range of wells, the calculated concentrations for individual
experiments give comparable values to one another. Our calcu-
lations indicate a dynamic range spanning nearly three orders of
magnitude (the bracket in Fig. 5). For example, the range from
about 5 negative to 5 positive wells corresponds to the range of
concentrations of about 1.5  103 DNA molecules mL1 to 2.1 
106 DNA molecules mL1. The two highest concentrations
underestimate the actual concentration as they saturated the
system and were expected to have all positive wells. This indicates
that a small percentage of false negatives is present in this system
(e.g. the defect in Fig. 3a), and that if less than 5 wells are
negative the sample should be retested at a diluted concentration.
Comparing the estimated concentrations from two separate
experiments would reveal whether the first result represented
correct concentration or was due to wells with false negative
signals.Fig. 5 Analysis of experimental digital PCR data and of confidence
intervals predicted by eqn (3). The expected concentration is shown by
the blue dashed line, error bars represent the 95% confidence interval.
High concentrations saturate the system resulting in incorrect, too-low
measurements. The rest of the range gives a more accurate measurement,
particularly the range indicated by the bracket. *This experiment resulted
in 1280 positive wells so only a lower limit can be determined.
This journal is ª The Royal Society of Chemistry 2010Conclusions
Here we found that the SlipChip was capable of accurately
quantifying the amount of nucleic acid present in a sample using
standard thermal cycling PCR techniques in a ‘‘digital format’’.
The SlipChip contained 1280 wells designed to separate micro-
litre sample into 1280 droplets of 2.6 nL each, and was capable
of detecting the template DNA at single copy level. The upper
limit of concentration that could be detected using this device can
be increased by decreasing the individual well volume and/or
increasing the number of wells on the SlipChip, and the sensi-
tivity of the device can be improved by increasing the total well
volume. We have previously incorporated 16 384 wells of pico-
litre volume on a single SlipChip with dimensions 1.5 inch by
1 inch (unpublished data). The digital PCR SlipChip would also
find additional applications if multiple samples could be screened
on the same chip as in SlipChips designed for protein crystalli-
zation experiments,22,23 immunoassays,25 and multiplex PCR.26
Multiplex digital PCR SlipChip could be designed to count
multiple targets in one experiment without interference by
increasing the number of wells and preloading different primer
sets in the circular wells. Other improvements to the digital PCR
SlipChip design include incorporating isothermal amplification
methods such as loop-mediated amplification (LAMP),41,42
recombinase polymerase amplification (RPA),43 nucleic acid
sequence-based amplification (NASBA),44–46 transcription-
mediated amplification (TMA),47,48 helicase-dependent
amplification,49,50 rolling-circle amplification (RCA),51,52 and
strand-displacement amplification (SDA),53,54 and incorporating
real-time PCR and multi-color probes, such as the Taqman
system and molecular beacons. Multi-color probes can be used to
apply digital PCR for multigene detection within a single cell to
study heterogeneity and also to provide a method to integrate
internal positive controls. Sample preparation such as nucleic
acid (DNA/RNA) extraction and purification integrated with the
SlipChip would further increase the applicability of this
approach.
The SlipChip platform should make digital PCR widely
available, and provide a simple quantification of nucleic acids
for a wide range of applications. These applications will range
from quantification of nucleic acids in research, e.g. as is done
prior to sequencing,55 to diagnostic applications, e.g. in prenatal
diagnostics.5,56 The device could also be used for single cell
analysis such as detection of mutations,57 monitoring of gene
expression,58 and analysis of cellular heterogeneity.3,59,60
Another application of digital PCR on the SlipChip is the
detection and quantification of rare cells in the presence of
normal cells, by distinguishing between mutant and wild-type
template DNA or RNA without cross-interference. The Slip-
Chip has the potential to meet the requirements for an ideal
diagnostic test in the developing world: affordable, sensitive,
specific, user-friendly, rapid, equipment-free, and delivered to
those who need it.61 The current digital PCR SlipChip still
requires purified nucleic acid, thermal cycling, and fluorescent
readout. As non-thermal cycling methods, nucleic acid purifi-
cation methods, and simple readouts are incorporated with the
digital PCR SlipChip, it could become an analytical and diag-
nostic tool that is widely available, especially in resource-limited
settings.Lab Chip, 2010, 10, 2666–2672 | 2671
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